Co-Founder & Chief Operating Officer
Neo-Advent Technologies LLC
Alex Nivorozhkin is an entrepreneur and team builder in life sciences arena with significant track record in early technology development. He is a co-founding member of several pharma companies that raised substantial capital including Boston BioCom (partnered with Pfizer), Amorsa Therapeutics (partnered with Johnson & Johnson), and Neo-Advent Technologies (drug formulation and drug delivery CRO). He is a co-inventor of several drug candidates that have advanced to clinical trials and late pre-clinical studies. Alex conducted postdoctoral research in chemical enzymology at the University Paris-Sud, France, and the Department of Chemistry and Chemical Biology, Harvard University.
My research interests involve all aspects of the drug formulation and drug delivery for both small and large molecules. The therapeutic areas of interests are the diseases of the central nervous system and cancer.